PTC Therapeutics Inc (PTCT)
25.22
-0.19
(-0.75%)
USD |
NASDAQ |
Apr 24, 16:00
25.22
0.00 (0.00%)
After-Hours: 20:00
PTC Therapeutics Profit Margin (Quarterly): -50.74% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -50.74% |
| September 30, 2023 | -67.64% |
| June 30, 2023 | -93.02% |
| March 31, 2023 | -63.05% |
| December 31, 2022 | -102.1% |
| September 30, 2022 | -50.35% |
| June 30, 2022 | -91.88% |
| March 31, 2022 | -85.20% |
| December 31, 2021 | -86.71% |
| September 30, 2021 | -96.31% |
| June 30, 2021 | -101.5% |
| March 31, 2021 | -109.1% |
| December 31, 2020 | -62.55% |
| September 30, 2020 | -58.86% |
| June 30, 2020 | -241.1% |
| March 31, 2020 | -165.1% |
| December 31, 2019 | -80.53% |
| September 30, 2019 | -84.01% |
| June 30, 2019 | -48.86% |
| March 31, 2019 | -134.6% |
| December 31, 2018 | -55.98% |
| September 30, 2018 | -95.11% |
| June 30, 2018 | -13.85% |
| March 31, 2018 | -34.36% |
| Date | Value |
|---|---|
| December 31, 2017 | 1.63% |
| September 30, 2017 | -80.61% |
| June 30, 2017 | -36.44% |
| March 31, 2017 | -109.5% |
| December 31, 2016 | -106.4% |
| September 30, 2016 | -153.0% |
| June 30, 2016 | -248.9% |
| March 31, 2016 | -218.2% |
| December 31, 2015 | -400.1% |
| September 30, 2015 | -442.1% |
| June 30, 2015 | -566.3% |
| March 31, 2015 | -506.7% |
| December 31, 2014 | -196.4% |
| September 30, 2014 | -3.42K% |
| June 30, 2014 | -1.77K% |
| March 31, 2014 | -154.1% |
| December 31, 2013 | -245.0% |
| September 30, 2013 | -28.57% |
| June 30, 2013 | -248.6% |
| March 31, 2013 | -241.8% |
| December 31, 2012 | -106.0% |
| September 30, 2012 | -120.8% |
| June 30, 2012 | -100.1% |
| March 31, 2012 | -61.36% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-241.1%
Minimum
Jun 2020
-48.86%
Maximum
Jun 2019
-91.50%
Average
-85.20%
Median
Mar 2022
Profit Margin (Quarterly) Benchmarks
| Sarepta Therapeutics Inc | 11.51% |
| Catalyst Pharmaceuticals Inc | 31.51% |
| Pfizer Inc | -23.64% |
| Geron Corp | -226.0K% |
| Perspective Therapeutics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -40.12% |
| Return on Invested Capital | -137.9% |
| Gross Profit Margin (Quarterly) | 90.52% |
| Operating Margin (Quarterly) | 1.02% |
| Return on Net Operating Assets | -63.20% |